Europe Metabolomics Services Market

Market Introduction

The European metabolomics services market is divided into Germany, the UK, France, Italy, Spain, and Rest of Europe. The region holds a significant market share in the metabolomics services market. Europe occupies a significant position in the metabolomics services market and is estimated to register a robust growth rate over the forecast period. The market growth in the region is expected due growing life science research and increase in the investment for research and development. Germany held rime share in the Europe region as it has the largest medical research industry in the European region accounted to be the third largest in the world. The country is expected to dominate the most significant medical research industry during the forecast period. Besides, Germany has witnessed a tremendous increase in cancer cases in recent years; for instance, according to the Global Cancer Observatory, in 2020, a total 6,28,519 number of new cases in both sexes and all ages were found, along with cases of 69 697 (11.1%) breast cancer, 67 959 (10.8%) Prostate cancer, 64 804 (10.3%) Lung cancer, 57 528 (9.2%) Colorectum cancer, 35 147 (5.6%) Bladder cancer, and 333 384 (53%) Other cancers. Metabolomics services is widely used in the detecting a wide range of metabolites in tissues and biofluids; thus, the demand for metabolomics services is increasing in the country. Rise in adoption of metabolomics and investments by the market players is the major factor driving the growth of the Europe metabolomics services market.

The Europe metabolomics services market, based on service type, is segmented into targeted metabolomics service and untargeted metabolomics service. The targeted metabolomics service segment led the market in 2020. Targeted metabolomics is a quantitative method that involves the estimation of a group of metabolites with the help of 15N or 13C compounds. Various companies offer targeted metabolomics services. By quantifying the small molecules and comparing them against established standards, they can target metabolomics services to precisely observe the dynamic metabolic process, reveal appropriate metabolic mechanisms, and verify possible metabolic biomarkers. Utilizing state-of-the-art LC-MS/MS systems and techniques, metabolic service providers offer validated workflows of targeted metabolomics such as vitamins, amino acids, hormones, and many small molecules.

Europe Metabolomics Services Strategic Insights

Strategic insights for the Europe Metabolomics Services provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Metabolomics Services Report Scope

Europe Metabolomics Services Regional Insights

The geographic scope of the Europe Metabolomics Services refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The metabolomics services market in Europe is expected to grow from US$ 128.72 million in 2021 to US$ 484.02 million by 2028; it is estimated to grow at a CAGR of 20.8% from 2021 to 2028. The market players associated with metabolomics are actively exploring the possible innovative technologies to facilitate researchers and medical care. Biomarkers have extensive application in personalized cancer therapy. Moreover, the market players are exploring advanced methods and technologies for diagnostic applications.  For instance, in April 2021, IMAGEENS, a Paris-based medical Artificial Intelligence (AI) startup, expedited the development and commercialization of ArtFun+, an artificial intelligence software and its prognostic biomarkers for cardiovascular imaging, and raised funding of € 1.2 million for the same. Thus, such innovative approaches of market players are expected to open up new scope for the market.

Key Market Segments

The Europe metabolomics services market has been segmented based on service type, application, and country. On the basis of service type, the Europe metabolomics services market is segmented into targeted metabolomics service and untargeted metabolomics service. The targeted metabolomics service segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. Based on application, the market is segmented into pharmaceutical and biotechnology industry, agritech, and environment. The pharmaceutical and biotechnology industry segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. Likewise, the pharmaceutical and biotechnology industry segmented is categorized into biomarker discovery, drug discovery, toxicological testing, and others.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on metabolomics services market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Afekta Technologies Ltd.; BASF SE; biocrates life sciences ag; Creative Proteomics; Fred Hutchinson Cancer Research Center; Metabolon, Inc.; metaSysX; MS-Omics; and RTI International are among others.

Reasons to buy report

• To understand the Europe metabolomics services market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for Europe metabolomics services market
• Efficiently plan M&A and partnership deals in Europe metabolomics services market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Europe metabolomics services market
• Obtain market revenue forecast for market by various segments from 2021-2028 in Europe region.

Europe Metabolomics Services Market Segmentation

Europe Metabolomics Services Market –By

Service Type

• Targeted Metabolomics Service
• Untargeted Metabolomics Service

Europe Metabolomics Services Market –By Application

• Pharmaceutical and Biotechnology Industry
  • Biomarker Discovery
  • Drug Discovery
  • Toxicological Testing
  • Others
• Agritech
• Environment

Europe Metabolomics Services Market -By Country

• US
• Canada
• Mexico

Europe Metabolomics Services Market -

Company Profiles

• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe